REFERENCES
- Bohmer, T., Rydning, A. and Solberg, H.E. 1974. Carnitine levels in human serum in health and disease.
Clin. Chim. Acta 57:55-61.
- Brooks, H., Goldberg, L., Holland, R. et al. 1977. Carnitine-induced effects on cardiac and peripheral hemodynamics.
J. Clin. Pharmacol. 17:561-568.
- Christiansen, R., Bremer, J. 1976. Active transport of butyrobetaine and carnitine into isolated liver cells.
Biochim. Biophys. Acta 448:562-577.
- Lindstedt, S. and Lindstedt, G. 1961. Distribution and excretion of carnitine in the rat.
Acta Chem. Scand. 15:701-702.
- Rebouche, C.J. and Engel, A.G. 1983. Carnitine metabolism and deficiency syndromes.
Mayo Clin. Proc. 58:533-540.
- Rebouche, C.J. and Paulson, D.J. 1986. Carnitine metabolism and function in humans.
Ann. Rev. Nutr. 6:41-66.
- Scriver, C.R., Beaudet, A.L., Sly, W.S. and Valle, D. 1989.
The Metabolic Basis of Inherited Disease. New York: McGraw-Hill.
- Schaub, J., Van Hoof, F. and Vis, H.L. 1991.
Inborn Errors of Metabolism. New York: Raven Press.
- Marzo, A., Arrigoni Martelli, E., Mancinelli, A., Cardace, G., Corbelletta, C., Bassani, E. and Solbiati, M. 1991. Protein binding of L-carnitine family components.
Eur. J. Drug Met. Pharmacokin., Special Issue III: 364-368.
- Rebouche, C.J. 1991. Quantitative estimation of absorption and degradation of a carnitine supplement by human adults.
Metabolism 40:1305-1310.
Distributed by:
Rising Pharmaceuticals, Inc.
Allendale, NJ 07401
Manufactured by:
Lyne Laboratories, Inc.
Brockton, MA 02301
R4-7/11
|